# reload+after+2024-01-21 01:43:58.111338
address1§6310 Nancy Ridge Drive
address2§Suite 101
city§San Diego
state§CA
zip§92121
country§United States
phone§858 752 6170
website§https://www.cidara.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California.
fullTimeEmployees§73
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Jeffrey L. Stein Ph.D.', 'age': 68, 'title': 'President, CEO & Executive Director', 'yearBorn': 1955, 'fiscalYear': 2022, 'totalPay': 873250, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Preetam  Shah M.B.A., Ph.D.', 'age': 50, 'title': 'CFO, Chief Business Officer & Principal Accounting Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 577850, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Taylor  Sandison', 'age': 51, 'title': 'Chief Medical Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 632050, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kevin M. Forrest Ph.D.', 'age': 46, 'title': 'Founder and Chief Strategy Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 333313, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Shane M. Ward', 'age': 48, 'title': 'COO & Chief Legal Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Allison  Lewis CCP, SPHR', 'title': 'Senior Vice President of People & Culture', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Leslie  Tari Ph.D.', 'age': 56, 'title': 'Chief Scientific Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 845100, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Laura A. Navalta', 'title': 'Senior Vice President of Clinical Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Nicole  Davarpanah J.D., M.D.', 'title': 'Senior VP of Translational Research & Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§6
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.999
priceToSalesTrailing12Months§1.2435627
currency§USD
dateShortInterest§1702598400
forwardEps§-0.58
pegRatio§-0.04
exchange§NCM
quoteType§EQUITY
shortName§Cidara Therapeutics, Inc.
longName§Cidara Therapeutics, Inc.
firstTradeDateEpochUtc§1429104600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§d09eb400-8190-3726-9b22-86bfb18853b0
gmtOffSetMilliseconds§-18000000
targetHighPrice§7.0
targetLowPrice§3.0
targetMeanPrice§5.6
targetMedianPrice§6.0
recommendationMean§1.6
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§1.447
grossMargins§-0.33945
ebitdaMargins§-0.55832
trailingPegRatio§None
